527 related articles for article (PubMed ID: 12287020)
21. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
22. Estrogen component of OCs.
Kaunitz AM; Ory H
Dialogues Contracept; 1997; 5(4):1-6. PubMed ID: 12293158
[TBL] [Abstract][Full Text] [Related]
23. [Oral contraception: evolution of concepts over the last thirty years].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
[TBL] [Abstract][Full Text] [Related]
24. Expanded role for OCs. Question and answer.
Mishell Dr
Dialogues Contracept; 1994; 4(3):8. PubMed ID: 12345576
[TBL] [Abstract][Full Text] [Related]
25. Family planning saves lives.
Population Reference Bureau PRB. International Programs
Integration; 1992 Dec; (34):18-25. PubMed ID: 12317826
[TBL] [Abstract][Full Text] [Related]
26. [Stroke and combined oral contraceptives].
Rancurel G; Kieffer E; Buge A
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):137-46. PubMed ID: 12280200
[TBL] [Abstract][Full Text] [Related]
27. Contraception and the big "C".
Chandran R
Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
[TBL] [Abstract][Full Text] [Related]
28. Choice at any cost.
Jacobson JL
World Watch; 1988; 1(2):30-8. PubMed ID: 12281497
[TBL] [Abstract][Full Text] [Related]
29. Oral steroidal contraception: scientific basis and recent development.
Sinnathuray TA
Malays J Reprod Health; 1988 Dec; 6(2):70-82. PubMed ID: 12342171
[TBL] [Abstract][Full Text] [Related]
30. OCs: international experts discuss state-of-the-art.
Contracept Technol Update; 1981 Nov; 2(11):147-51. PubMed ID: 12338027
[TBL] [Abstract][Full Text] [Related]
31. Prospective long-term study of women on different contraceptives.
IPPF Med Bull; 1976 Oct; 10(5):2-3. PubMed ID: 12307439
[TBL] [Abstract][Full Text] [Related]
32. IPPF statement on oral contraceptives and cancer of the breast.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1989 Apr; 23(2):4. PubMed ID: 12342374
[TBL] [Abstract][Full Text] [Related]
33. A perspective on the concept of "risk".
Westhoff CL
Dialogues Contracept; 1996; 5(1):8-9. PubMed ID: 12347723
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of fertility-regulating methods: a decade of research.
Skegg DC
Bull World Health Organ; 1999; 77(9):713-21. PubMed ID: 10534894
[TBL] [Abstract][Full Text] [Related]
35. OCs and genital tract malignancies.
Herbst AL
Dialogues Contracept; 1994; 4(3):5-7. PubMed ID: 12345575
[TBL] [Abstract][Full Text] [Related]
36. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
37. New Programme research on the safety of oral contraceptive pills.
Prog Hum Reprod Res; 1996; (39):1. PubMed ID: 12292197
[TBL] [Abstract][Full Text] [Related]
38. Patients with hematologic disorders need careful birth control counseling.
Neinstein Ls Katz B
Contracept Technol Update; 1985 Mar; 6(3):43-6. PubMed ID: 12266720
[TBL] [Abstract][Full Text] [Related]
39. Family planners need to absorb importance of mortality study.
Hatcher RA
Contracept Technol Update; 1982 Jul; 3(7):88-9. PubMed ID: 12279229
[TBL] [Abstract][Full Text] [Related]
40. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
Le Coutour X
NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
